Strongyloidiasis.
Mahmoud AA.
Clin Infect Dis. 1996 Nov;23(5):949-52; quiz 953. doi: 10.1093/clinids/23.5.949.
Strongyloidiasis Hyperinfection Syndrome in COVID-19 Positive Migrants Treated with Corticosteroids.
Jenks NP, Driscoll B, Locke T.
J Immigr Minor Health. 2022 Dec;24(6):1431-1434. doi: 10.1007/s10903-022-01386-w. Epub 2022 Aug 8.
Disseminated strongyloidiasis.
Cappello M, Hotez PJ.
Semin Neurol. 1993 Jun;13(2):169-74. doi: 10.1055/s-2008-1041122.
Human strongyloidiasis.
Grove DI.
Adv Parasitol. 1996;38:251-309. doi: 10.1016/s0065-308x(08)60036-6.
[Strongyloidiasis].
Hirata T, Saito A.
Nihon Rinsho. 2003 Feb;61 Suppl 2:644-8.
Strongyloidiasis in Africa: Systematic Review and Meta-Analysis on Prevalence, Diagnostic Methods, and Study Settings.
Hailu T, Nibret E, Amor A, Munshea A.
Biomed Res Int. 2020 Nov 15;2020:2868564. doi: 10.1155/2020/2868564. eCollection 2020.
Strongyloidiasis: the most neglected tropical disease in Ethiopia.
Tiruneh A, Zemene E, Mekonnen Z.
Infect Dis Poverty. 2021 May 7;10(1):65. doi: 10.1186/s40249-021-00851-2.
Strongyloidiasis with emphasis on human infections and its different clinical forms.
Toledo R, Muñoz-Antoli C, Esteban JG.
Adv Parasitol. 2015 Apr;88:165-241. doi: 10.1016/bs.apar.2015.02.005. Epub 2015 Mar 23.
Strongyloidiasis: A Disease of Socioeconomic Disadvantage.
Beknazarova M, Whiley H, Ross K.
Int J Environ Res Public Health. 2016 May 20;13(5):517. doi: 10.3390/ijerph13050517.
Strongyloidiasis. The protean parasitic infection.
Schneider JH, Rogers AI.
Postgrad Med. 1997 Sep;102(3):177-84. doi: 10.3810/pgm.1997.09.320.
